TURRINI, Fabiola
 Distribuzione geografica
Continente #
NA - Nord America 336
EU - Europa 226
AS - Asia 112
OC - Oceania 1
Totale 675
Nazione #
US - Stati Uniti d'America 334
GB - Regno Unito 94
CN - Cina 76
SE - Svezia 28
SG - Singapore 27
FI - Finlandia 19
IE - Irlanda 18
FR - Francia 15
RU - Federazione Russa 15
DE - Germania 13
BE - Belgio 9
IT - Italia 8
KR - Corea 7
UA - Ucraina 3
AT - Austria 1
CA - Canada 1
CR - Costa Rica 1
EE - Estonia 1
HR - Croazia 1
IN - India 1
NL - Olanda 1
NZ - Nuova Zelanda 1
UZ - Uzbekistan 1
Totale 675
Città #
Southend 85
Chandler 65
Woodbridge 37
Ann Arbor 34
Jacksonville 33
Houston 32
Ashburn 25
Beijing 22
Singapore 22
Dublin 18
New York 14
Jinan 10
Wilmington 10
Brussels 9
Lawrence 7
Princeton 7
Seoul 7
Nanjing 6
Los Angeles 5
Hebei 4
Helsinki 4
Santa Clara 4
Boardman 3
Guangzhou 3
Romola 3
Shenyang 3
Tianjin 3
Verona 3
Dearborn 2
San Francisco 2
Amsterdam 1
Atlanta 1
Auburn Hills 1
Auckland 1
Boston 1
Clearwater 1
Espoo 1
Frankfurt am Main 1
Haikou 1
Hangzhou 1
Jiaxing 1
Kemerovo 1
Kochi 1
London 1
Nanchang 1
Ottawa 1
Riva 1
San Diego 1
San José 1
Sindelfingen 1
Taiyuan 1
Tallinn 1
Tashkent 1
Vienna 1
Washington 1
Zagreb 1
Zhengzhou 1
Totale 509
Nome #
CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3. 132
Potential role of MTNR1B locus in regulating beta cell function and glucose levels in patients with newly diagnosed type 2 diabetes 113
Variants in CACNA1E affect beta cell function and glucose homeostasis in newly diagnosed type 2 diabetes patients 96
Genetic variability of G6PC2 influences beta cell function and insulin sensitivity in patients with newly diagnosed type 2 diabetes 95
Body mass index is a potential modifier of the influence on beta cell function exerted by SLC30A8 and KCNJ11 diabetes risk variants in patients with newly diagnosed type 2 diabetes 91
Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2. 80
PPARgamma Pro12Ala and ADAMTS9 rs4607103 are determinants of insulin sensitivity in both non-diabetic and type 2 diabetic Italian subjects 76
Totale 683
Categoria #
all - tutte 2.185
article - articoli 680
book - libri 0
conference - conferenze 1.505
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202055 0 0 0 0 7 11 9 3 1 13 7 4
2020/202154 2 21 1 4 9 5 2 2 1 2 4 1
2021/202265 9 11 0 10 0 2 1 3 4 3 4 18
2022/2023148 11 22 18 28 11 28 3 5 16 3 3 0
2023/202496 1 5 7 10 15 26 0 6 0 14 8 4
2024/202568 9 8 7 41 3 0 0 0 0 0 0 0
Totale 683